Finland vs North Macedonia: Previously treated cases tested for RR-/MDR-TB
Finland
33.0%
in 2024
North Macedonia
29.0%
in 2024
Finland rank
158th
North Macedonia rank
161st
Previously treated cases tested for RR-/MDR-TB over time
- Finland
- North Macedonia
How they compare
Finland currently reports 33.0% against 29.0% in North Macedonia, a difference of 4.0%.
That makes Finland's figure about 1.1 times North Macedonia's.
The two have swapped places 4 times across 20 shared years of data; in 2005 it was Finland ahead.
Finland ranks 158th and North Macedonia ranks 161st of 180 countries.
Across the 3 decades both report, Finland averaged higher in 1 and North Macedonia in 2.
Head to head by decade
| Decade | Finland | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.8% | 33.2% | 32.6% | Finland |
| 2010s | 48.5% | 71.8% | 23.3% | North Macedonia |
| 2020s | 42.0% | 77.4% | 35.4% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Finland or North Macedonia?
- Finland, at 33.0% against 29.0% in North Macedonia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Finland and North Macedonia?
- 4.0%, with Finland ahead.
- How many years of comparable data are there for Finland and North Macedonia?
- 20 years are reported by both, from 2005 to 2024.
- How do Finland and North Macedonia rank globally for previously treated cases tested for rr-/mdr-tb?
- Finland ranks 158th and North Macedonia ranks 161st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.